Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2012
05/31/2012WO2012069415A1 Oligosaccharide mixture and food product comprising this mixture, especially infant formula
05/31/2012WO2012069402A1 Substituted cyclopentyl - azines as casr- active compounds
05/31/2012WO2012069394A1 Multicomponent system of rosuvastatin calcium salt and sorbitol
05/31/2012WO2012069380A1 Antifungal 5,6-dihydro-4h-pyrrolo[1,2-a][1,4]-benzodiazepines and 6h-pyrrolo[1,2-a][1,4]benzodiazepines substituted with phenyl derivatives
05/31/2012WO2012069322A1 Protective hydrocolloid for active ingredients
05/31/2012WO2012069275A1 Glycine derivatives and their use as muscarinic receptor antagonists
05/31/2012WO2012069221A1 Therapeutical method for the treatment of the leber optic
05/31/2012WO2012069202A1 Imidazo [1,2-b] pyridazine and imidazo [4,5-b] pyridine derivatives as jak inhibitors
05/31/2012WO2012069175A1 New pyrazole derivatives having crth2 antagonistic behaviour
05/31/2012WO2012069150A2 Cytoprotectant agents for the prevention of drug-associated side-effects
05/31/2012WO2012069149A1 Solution comprising cyclic oligopeptides
05/31/2012WO2012068998A2 Triamcinolone acetonide ophthalmic preparation and preparation method thereof
05/31/2012WO2012068981A1 6-deoxy-6-thioether-amino acid cyclodextrin derivatives and preparation method thereof
05/31/2012WO2012068962A1 Use of compound salvia miltiorrhiza preparation in preparing medicament for resisting pulmonary hypertension
05/31/2012WO2012068958A1 Antianxiety and sleep disorder improving use of albiflorin or metabolite thereof in
05/31/2012WO2012068783A1 Compositions of rotigotine, derivatives thereof, or pharmaceutically acceptable salts of rotigotine or its derivative
05/31/2012WO2012068780A1 Gelatin microsphere for pharmaceutical use and preparation method thereof
05/31/2012WO2012068714A1 Hair growth promoter
05/31/2012WO2012068702A1 Benzo 5-membered unsaturated heterocyclic compounds and preparation methods thereof
05/31/2012WO2012068627A1 Peptides for the specific binding of rna targets
05/31/2012WO2012068622A1 Compounds for treating respiratory syncytial virus infections
05/31/2012WO2012068612A1 Methods of treating eye diseases associated with inflammation and vascular proliferation
05/31/2012WO2012054695A8 Antimicrobial amphiphiles and methods for their use
05/31/2012WO2012048059A3 Bepotastine compositions
05/31/2012WO2012048058A3 Developing potent urate transporter inhibitors: compounds designed for their uricosuric action
05/31/2012WO2012047993A3 N-hydroxypyrimidine-2,4-diones as inhibitors of hiv and hcv
05/31/2012WO2012047870A3 Antimicrobial preservation of propofol emulsions
05/31/2012WO2012047848A3 Allergen deactivator composition, articles and methods
05/31/2012WO2012047645A3 Combination treatment for rosacea
05/31/2012WO2012047628A3 Methods of managing blood sugar levels and compositions related thereto
05/31/2012WO2012047017A3 2,3-dihydro-isoindol-1-one derivative and a composition comprising the same
05/31/2012WO2012044561A3 2-alkoxy pyrimidine pde10 inhibitors
05/31/2012WO2012042539A3 3 -azabicyclo [3.1.0] hexane compounds useful for the treatment of cns disorders
05/31/2012WO2012040719A3 Novel tlr4 inhibitors for the treatment of human infectious and inflammatory disorders
05/31/2012WO2012040595A9 Administration of serine protease inhibitors to the stomach
05/31/2012WO2012037485A9 Methods of inhibiting alphavirus replication and treating alphavirus infection
05/31/2012WO2012036512A3 Use of a compound for inducing differentiation of mesenchymal stem cells into cartilage cells
05/31/2012WO2012036430A3 Non-aqueous oily injectable formulation exhibiting preservative efficacy
05/31/2012WO2012033348A3 Composition for the prevention or treatment of allergic diseases comprising 2-linoleoyl glycerol
05/31/2012WO2012030626A3 Design of oligonucleotide analogs as therapeutic agents
05/31/2012WO2012027601A9 Methods targeting mir-33 micrornas for regulating lipid metabolism
05/31/2012WO2012026813A3 Analogs of geranylgeranylacetone and uses thereof
05/31/2012WO2012024363A3 Compounds and methods for the treatment or prevention of flaviviridae viral infections
05/31/2012WO2012022659A9 Synergistic activity of modulators of the no metabolism and of nadph oxidase in the sensitization of tumour cells
05/31/2012WO2012021486A3 Acylsulfonamides and processes for producing the same
05/31/2012WO2012016683A3 Oral dosage form of pregabalin
05/31/2012WO2012015986A3 Substituted dioxopiperidinyl phthalimide derivatives
05/31/2012WO2012015914A3 Aryl hydrocarbon receptor (ahr) modifiers as novel cancer therapeutics
05/31/2012WO2012012712A3 Tricyclic proteasome activity enhancing compounds
05/31/2012WO2012012257A3 BIVALENT MULTIFUNCTIONAL LIGANDS TARGETING Aβ OLIGOMERS AS TREATMENT FOR ALZHEIMER'S DISEASE
05/31/2012WO2012011752A3 Novel long-acting glucagon conjugate and pharmaceutical composition comprising the same for the prevention and treatment of obesity
05/31/2012WO2012011740A3 Method for preparing microspheres and microspheres produced thereby
05/31/2012WO2012011707A3 Substituted pyridinone derivatives and methods for manufacturing the same
05/31/2012WO2012008765A3 Pharmaceutical composition for treating or preventing cancer
05/31/2012WO2012008764A3 Composition for inducing multiple nuclear division of cells
05/31/2012WO2012007729A3 Pharmaceutical compositions comprising r (+) budesonide and one or more bronchodilators
05/31/2012WO2012006298A3 Formulation for co-therapy treatment of diabetes
05/31/2012WO2011162562A3 [6+5] fused bicycles as a thrombin antagonist, process for preparation thereof and pharmaceutical compositions containing the bicycles
05/31/2012WO2011156479A9 Trkb agonists and methods of use
05/31/2012WO2011139253A3 Pharmaceutical compositions comprising ceftibuten
05/31/2012WO2011139246A8 Topical or injectable composition comprising humic acid salts and polyvinylpyrrolidone for the treatment of skin diseases
05/31/2012WO2011121034A3 Water-free pharmaceutical compositions suitable for local anaesthetics
05/31/2012WO2011101868A4 Stable pharmaceutical preparations containing clindamycin and benzoyl peroxide and method thereof
05/31/2012WO2011063776A3 Soluble beta-glucan-api complexes for pharmaceutical use
05/31/2012WO2011006040A3 Methods for treating polycystic kidney disease (pkd) or other cyst forming diseases
05/31/2012WO2010065674A9 Inhibitors of hcv ns5a
05/31/2012WO2007070376A8 Diagnosis, prognosis and monitoring of disease progression of systemic lupus erythematosus through blood leukocyte microarray analysis
05/31/2012US20120136220 Compositions and methods for enhancing brain function
05/31/2012US20120136157 Aryl ureas as kinase inhibitors
05/31/2012US20120136153 Camptothecin analogs and methods of preparation thereof
05/31/2012US20120136069 Alcoholic Pump Foam
05/31/2012US20120136068 Ameliorant for renal insufficiency
05/31/2012US20120136066 Glomerulonephritis Treatment
05/31/2012US20120136065 Treatment of CNS Disorders with trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Napthalenamine
05/31/2012US20120136064 Methods for screening to identify therapeutic agents for alzheimer's disease and use thereof
05/31/2012US20120136063 Fty720-derived anticancer agents
05/31/2012US20120136062 Novel complex for treatment and/or prophylaxis of parasitic infections
05/31/2012US20120136061 Lycopene and resveratrol compositions for nk cell activation resulting in anti-neoplastic effect
05/31/2012US20120136060 Immediate release and sustained release ibuprofen dosing regimen
05/31/2012US20120136059 Combinations of adapalene and benzoyl peroxide for treating acne lesions
05/31/2012US20120136058 Method For Increasing The Solubility Of Methionine By Mineral Addition And Acid Treatment
05/31/2012US20120136057 Hydroxy fatty acid compounds and uses thereof for disease treatment and diagnosis
05/31/2012US20120136055 Semi-solid compositions and pharmaceutical products
05/31/2012US20120136054 Materials and methods for measuring nitric oxide levels in biological fluids
05/31/2012US20120136053 Copepod oil composition, formulations comprising the oil composition, and the use thereof to reduce accumulation of visceral fat, improve glucose tolerance, and prevent or treat obesity related diseases and disorders
05/31/2012US20120136052 Substituted acylanilides and methods of use thereof
05/31/2012US20120136050 Use of a melatonin agonist for the treatment of sleep disorders including primary insomnia
05/31/2012US20120136049 Antibacterial agent
05/31/2012US20120136048 Topical, periocular, or intraocular use of tocotrienols for the treatment of ophthalmic diseases
05/31/2012US20120136047 Neuroprotective compositions and methods
05/31/2012US20120136046 Method of treating age related disorders
05/31/2012US20120136045 Screening for compounds that modulate gpr3-mediated beta-arrestin signaling and amyloid beta peptide generation
05/31/2012US20120136044 Compositions And Methods Of Inhibiting NADPH Oxidase Expression
05/31/2012US20120136043 Antisense oligonucleotides (odn) against smad7 and uses thereof in medical field
05/31/2012US20120136042 Carbohydrate conjugates as delivery agents for oligonucleotides
05/31/2012US20120136041 Treating Ocular Diseases Using Peroxisome Proliferator-Activated Receptor Delta Antagonists
05/31/2012US20120136040 Hybrid interfering rna
05/31/2012US20120136039 Single nucleotide polymorphism (snp) targeting therapies for the treatment of huntington's disease
05/31/2012US20120136038 Novel Polymorphs Of Azabicyclohexane
05/31/2012US20120136037 Deuterium-enriched ruboxistaurin
1 ... 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 ... 7860